ClinicalTrials.gg
RecruitingNCT03356132STEPS AUpdated Mar 16, 2026

An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants

An observational study in Breast Implant; Complications, Quality of Life and Satisfaction, sponsored by Silimed Industria de Implantes Ltda. Recruiting at 1 site in Brazil. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-16.

Sponsored by Silimed Industria de Implantes Ltda · Observational

From the registry’s dates

  • Started Jul 2018; still recruiting 8 years 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
632
Ages
18 Years and older
Sex
Female
01

Study summary

The study investigates the safety and performance of Silimed® silicone gel breast implants with a textured surface and Silimed® silicone gel breast implants with polyurethane coated surface. Female patients who underwent primary or secondary breast augmentation using Silimed® breast implants will be followed-up through 10 years. The safety of each type of Silimed® breast implant is going to be assessed by estimating the known and unexpected short- and long-term risk / adverse event rates. The performance of each type of Silimed® breast implant is going to be assesses by estimating the satisfaction and quality of life after implantation.

02

Conditions studied

  • Breast Implant; Complications
  • Quality of Life
  • Satisfaction

Browse trials for

Keywords

  • breast implant
  • complication
  • satisfaction
  • quality of life
  • augmentation
  • textured
  • polyurethane
03

In context

Personal Satisfaction

541 studies on the registry are indexed under Personal Satisfaction; 93 are open to participants now.

This study's planned enrollment of 632 is above the median of 180 across 115 observational studies indexed under Personal Satisfaction.

Browse Personal Satisfaction studies →

Lead sponsor

Silimed Industria de Implantes Ltda is the lead sponsor of 6 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women aged 18 years old or older who have undergone breast augmentation using Silimed® silicone gel-filled breast implants with textured surface or Silimed® silicone gel-filled breast implants with polyurethane foam coated surface.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • provide written .
  • female at birth
  • be 18 years of age or older
  • have received breast implant(s) for indication of primary or secondary augmentation until 21 days before (including the visit window)
  • having received a breast implant with a textured surface or a breast implant with a surface coated with Silimed® polyurethane foam
  • ability to comply with the protocol throughout the follow-up period.

Exclusion criteria

Exclusion Criteria:

  • mammary reconstruction in at least one breast or augmentation after previous reconstruction,
  • pregnancy informed or breastfeeding at the inclusion moment,
  • advanced fibrocystic disease at the time of implantation,
  • neoplasia of any type not yet treated or being treated at the time of implantation, infection in activity not yet treated or being treated at any site at the time of implantation,
  • reporting or recording of adverse reactions or intolerance to polyurethane or silicone prior to implantation,
  • immune diseases affecting active connective tissue or (eg, lupus erythematosus, discoid lupus, scleroderma, etc.) at the time of implantation,
  • signs of inflammation of the breast or implant site at the time of implantation,
  • Increased risk of immediate postoperative complications due to use of illicit drugs or medications,
  • Increased risk of immediate post-surgical complications caused by illicit drug use or medication use,
  • have participated in another clinical study up to 6 months prior to the placement of the implant,
  • any other condition which, based on the opinion of the investigator or designee, may prevent the provision of , renders participation in the study is unsafe, compromises adherence to the protocol, complicates the interpretation of data from the study outcome, or otherwise interferes with the achievement of study objectives.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
632 participants (estimated)
Patient registry
No

Groups and cohorts

  • Textured Group

    Women undergoing primary and secondary breast augmentation with Silimed® Textured Silicone Gel-Filled Breast Implant.

    Device: Silimed® Textured Silicone Gel-Filled Breast Implant

  • Polyurethane Group

    Women undergoing primary and secondary breast augmentation with Silimed® Polyurethane Foam Covered Silicone Gel-Filled Breast Implant

    Device: Silimed® Polyurethane Foam Covered Silicone Gel-Filled Breast Implant

Interventions

  • DeviceSilimed® Textured Silicone Gel-Filled Breast Implant

    Women undergoing primary and secondary breast augmentation using Silimed® Textured Silicone Gel-Filled Breast Implant.

  • DeviceSilimed® Polyurethane Foam Covered Silicone Gel-Filled Breast Implant

    Women undergoing primary and secondary breast augmentation using Silimed® silicone gel-filled breast implants with polyurethane foam covered surface.

06

What researchers measure

Primary outcomes

  1. Expected Adverse Events

    Estimate the known short-term and long-term risk / adverse event rate for Silimed® silicone gel-filled breast implants with textured surface and Silimed® silicone gel-filled breast implants with polyurethane foam covered surface

    Time frame: Every three years through the 10 years length of the study.

  2. Unexpected Adverse Events

    Estimate the unknown short-term and long-term risk / adverse event rate for Silimed® silicone gel-filled breast implants with textured surface and Silimed® silicone gel-filled breast implants with polyurethane foam covered surface

    Time frame: Every three years through the 10 years length of the study.

Secondary outcomes

  1. Patient's Satisfaction in Relation to Aesthetic Result

    Estimate the performance of Silimed® silicone gel-filled breast implants with textured surface and Silimed® silicone gel-filled breast implants with polyurethane foam covered surface through the satisfaction of the patient regarding the aesthetic result after breast augmentation. The assessment of patient's satisfaction will be done by means of a likert scale, where the following satisfaction options can be selected: 1 = definitely satisfied, 2 = satisfied, 3 = slightly satisfied, 4 = slightly dissatisfied and 5 = definitely unsatisfied.

    Time frame: Every three years through the 10 years length of the study.

  2. Patient's Satisfaction in General

    Estimate the performance of Silimed® silicone gel-filled breast implants with textured surface and Silimed® silicone gel-filled breast implants with polyurethane foam covered surface after breast augmentation by means of a questionnaire, the Breast Self-Assessment Questionnaire (BEQ-Brazil), which consist of 55 questions related to satisfaction and comfort with the overall appearance of the breasts.

    Time frame: Every three years through the 10 years length of the study.

  3. Evaluator's Satisfaction in Relation to Aesthetic Result

    Estimate the performance of Silimed® silicone gel-filled breast implants with textured surface and Silimed® silicone gel-filled breast implants with polyurethane foam covered surface through the satisfaction of the evaluator regarding the aesthetic result after patient's breast augmentation. The assessment of evaluator's satisfaction will be done by means of a likert scale, where the following satisfaction options can be selected: 1 = definitely satisfied, 2 = satisfied, 3 = slightly satisfied, 4 = slightly dissatisfied and 5 = definitely unsatisfied.

    Time frame: Every three years through the 10 years length of the study.

  4. Patient's Quality of Life

    Estimate the performance of Silimed® silicone gel-filled breast implants with textured surface and Silimed® silicone gel-filled breast implants with polyurethane foam covered surface through the quality of life of the patient after breast augmentation. The assessment of patient's quality of life will be done by means of the Rosemberg Global Self-Esteem Scale, in order to evaluate the overall self-esteem of the sample.

    Time frame: Every three years through the 10 years length of the study.

07

Study locations

1 of 1 sites recruiting
  • Perfektua Serviços Médicos Ltda
    Niterói, Rio de Janeiro 24230-052, Brazil
    Recruiting
    • Celso EJ Boechat, MD · Contactceboechat@gmail.com · +55 21 99624-2604
    • Celso EJ Boechat, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — All IPD that underlie results in a publication will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: The IPD will be shared starting 6 months after the end of the study.

Access criteria: It was not defined yet.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03356132
Lead sponsor
Silimed Industria de Implantes Ltda
Responsible party
Sponsor
First posted
Nov 29, 2017
Start date
Jul 31, 2018
Primary completion
Dec 2036 (estimated)
Completion
Dec 2036 (estimated)
Last update
Mar 16, 2026

Study contacts

Ludmila C Donato
Contact
pesquisaclinica@silimed.com.br
+552198399-0573
Maria Clara M Sodré
Contact
pesquisaclinica@silimed.com.br
+55212784-2764
Celso EJ Boechat, MD
principal investigator · Perfektua Serviços Médicos Ltda

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion